Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senate
Pharma
WuXi service providers eye asset sales amid BIOSECURE threat: FT
As the BIOSECURE Act works through the U.S. legislative branch, two companies named in the bill are weighing asset sales, The Financial Times reports.
Fraiser Kansteiner
Oct 3, 2024 9:47am
After BIOSECURE passes in House, targeted companies play defense
Sep 10, 2024 10:40am
Senate unanimously passes bill targeting 'patent thickets'
Jul 12, 2024 9:28am
Sanders seeks subpoena for Novo exec to answer pricing questions
Jun 12, 2024 8:01am
WuXi AppTec allegedly handed over client's IP to China: report
Mar 28, 2024 10:21am
CEOs from BMS, J&J and Merck defend high drug costs to senators
Feb 8, 2024 3:05pm
